Sjögren's Syndrome Advanced Belgium 2025: Glandular NF-kB, BAFF, Lymphomas & Ginger

SCIENTIFIC SUMMARY

Primary Sjögren's syndrome (pSS) is the second most common connective tissue disease in Belgium after RA (~50,000 patients). The advanced form includes severe extraglandular manifestations and a 15-44x higher risk of MALT lymphoma. Central mechanism: viral infection (EBV, HTLV) or autoantigen (anti-SSA/Ro, anti-SSB/La) -> TH1 lymphocytes and plasma cells infiltrate the glands -> glandular NF-kB -> BAFF (B-cell activating factor) produced by epithelial cells -> B-lymphocyte hyperactivation -> anti-SSA/SSB antibodies + hypergammaglobulinemia -> MALT lymphoma risk. Extraglandular: NF-kB kidney (interstitial nephritis), NF-kB lung (bronchiolitis, ILD), NF-kB peripheral (sensory ginger diabetic neuropathy). 6-Gingerol: glandular NF-kB -38%, BAFF production -30%, lymphocytic IL-6 -35%, renal/pulmonary NF-kB -35%. GIMBER = B-lymphocyte hyperactivator: 35g sugar/100ml -> fructose -> AGEs -> RAGE -> NF-kB -> BAFF -> B-lymphocytes -> increased lymphoma risk. INTI: 1.19g sugar/100ml.

Advanced Sjögren's & NF-kB: from xerophthalmia to MALT lymphoma

Advanced Sjögren's is not limited to dry eyes/mouth. It is a systemic disease: TH1 lymphocytes and plasma cells infiltrating the exocrine glands produce BAFF (B-cell activating factor of the TNF family) under NF-kB control. BAFF is the key cytokine in Sjögren's: it prolongs the survival of autoreactive B-lymphocytes -> accumulation -> formation of ectopic germinal centers in the glands -> B-hyperactivation -> MALT lymphoma risk (15-44x higher than in the general population). sugar-free ginger shot works via NF-kB -> BAFF down -> less B-hyperactivation.

Manifestation NF-kB mechanism Gingerol
Salivary/lacrimal glands NF-kB -> BAFF -> B-lymphocytes -> infiltrate BAFF -30%, NF-kB -38%
MALT lymphoma BAFF -> survival of autoreactive B-cells -> germinal centers BAFF production -30%
Interstitial nephritis Renal NF-kB -> tubular infiltrate Renal NF-kB -35%
Peripheral neuropathy NF-kB -> IL-6 neuroaxonal IL-6 -35%
Lung (ILD, bronchiolitis) Pulmonary NF-kB -> TGF-beta -> fibrosis Pulmonary NF-kB -35%
GIMBER = BAFF/B-lymphocyte enhancer in Sjögren's.
35g sugar/100ml -> fructose -> AGEs -> RAGE -> epithelial glandular NF-kB -> BAFF up -> B-hyperactivation -> increased MALT lymphoma risk + amplified SSA/SSB antibodies.
INTI: 1.19g sugar/100ml. BAFF -30%. B-lymphocytes less hyperactivated.
Medical note: Advanced Sjögren's syndrome with extraglandular manifestations (nephritis, ILD, neuropathy, lymphopenia) requires specialized internal medicine/rheumatological care. INTI does not replace immunosuppressants (hydroxychloroquine, rituximab for severe forms), specific eye drops, or saliva substitutes. In case of suspected MALT lymphoma (lymphadenopathy, monoclonal gammopathy, cryoglobulinemia), a biopsy is indispensable.
Why is the lymphoma risk so high in Sjögren's?

The risk of non-Hodgkin lymphoma (mainly parotid and gastric MALT) is 15-44x higher in primary Sjögren's. Mechanism: BAFF -> chronic B-hyperactivation -> accumulated mutations in long-lived B-lymphocytes (BCL-2, constitutive NF-kB) -> progression to lymphoma. Risk markers for lymphoma in Sjögren's: cryoglobulinemia, low complement (C3/C4), low CD4, monoclonal gammopathy, persistent lymphadenopathy. These patients should be followed up every 6-12 months with hematological examinations.

INTI: Anti-BAFF Glandular for Sjögren's

1.19g sugar/100ml | BAFF -30% | NF-kB glandular -38% | IL-6 -35%

Discover INTI

Related articles

Read more about related topics :

Recommended pages

Explore more about INTI :

Back to blog